ISBN 978-0-525-57451-4
Ingredients WATER, METHYLPROPANEDIOL, GLYCERIN, BETA-GLUCAN, DIMETHICONE, NIACINAMIDE, CYCLOPENTASILOXANE, BETAINE, POLYGLYCERIN-3, ALGAE EXTRACT, ECLIPTA LEAF EXTRACT, CENTELLA EXTRACT, FIG FRUIT EXTRACT, LICORICE EXTRACT, PANAX GINSENG EXTRACT, ULMUS DAVIDIANA EXTRACT, CAUDATUS SEED EXTRACT, LECITHIN, KERNEL OIL, SODIUM ACRYLATE/SODIUM ACRYLOYLDIMETHYL TAURATE COPOLYMER, SODIUM POLYACRYLATE, ETHYLHEXYL STEARATE, ISOHEXADECANE, PANTHENOL, DIMETHICONOL, BUTYLENE GLYCOL, GLUTATHIONE (1000PPM), RICE FERMENT, SORBITAN OLEATE, TRIETHOXYCAPRYLYLSILANE, TRIDECETH-6, SQUALANE, FRUCTOOLIGOSACCHARIDES, HYDROGENATED POLYSOBUTENE, DISODIUM EDTA, ISONONYL ISONONANOATE, POLYGLYCERYL-10 STEARATE, CETEARYL ALCOHOL, STEARIC ACID, SHEA BUTTER, POLYGLYCERYL-2 DIPOLYHYDROXYSTEARATE, HYALURONIC ACID, INULIN LAURYL CARBAMATE, PEARL POWDER, CARBOMER, CERAMIDE NP, DISODIUM STEAROYL GLUTAMATE, PALMITOYL PENTAPEPTIDE-4, POLYSORBATE 80, POLYSORBATE 20, FRANGRANCE, 1,2-HEXANEDIOL, HYDROXYACETOPHENONE, TITANIUM DIOXIDE (CI 77891) *** Ingredients are subject to change at the manufacturer's discretion
It is important to note that few studies have examined omics biomarkers in relationship to existing clinical criteria, such as coma or a constellation of clinical and laboratory findings (i.e., Kings College Criteria) currently in use by clinical practitioners as a prognostic indicator
Cargo selection in these pathways is often achieved via the binding of an autophagy receptor that harbors a consensus LC3-interacting region (LIR), a stretch of 4 amino acids to facilitate its direct binding to the LDS (LIR-docking site) of LC3 orthologs
